1 |
Al Jaber J, Haque S, Noor H, Ibrahim B, Al Suwaidi J. Thyrotoxicosis and coronary artery spasm: case report and review of the literature. Angiology 2010;61:807-12.
DOI
|
2 |
Wei JY, Genecin A, Greene HL, Achuff SC. Coronary spasm with ventricular fibrillation during thyrotoxicosis: response to attaining euthyroid state. Am J Cardiol 1979;43:335-9.
DOI
|
3 |
Chao MT, Wade C, Kronenberg F, Kalmuss D, Cushman LF. Women's reasons for complementary and alternative medicine use: racial/ethnic differences. J Altern Complement Med 2006;12:719-22.
DOI
|
4 |
Ernst E. Complementary/alternative medicine for hypertension: a mini-review. Wien Med Wochenschr 2005;155:386-91.
DOI
|
5 |
Choi YH, Chung JH, Bae SW, et al. Severe coronary artery spasm can be associated with hyperthyroidism. Coron Artery Dis 2005;16:135-9.
DOI
|
6 |
Bergeron GA, Goldsmith R, Schiller NB. Myocardial infarction, severe reversible ischemia, and shock following excess thyroid administration in a woman with normal coronary arteries. Arch Intern Med 1988;148:1450-3.
DOI
|
7 |
Gohar F, Greenfield SM, Beevers DG, Lip GY, Jolly K. Self-care and adherence to medication: a survey in the hypertension outpatient clinic. BMC Complement Altern Med 2008;8:4.
DOI
|
8 |
De Geest S, Sabate E. Adherence to long-term therapies: evidence for action. Eur J Cardiovasc Nurs 2003;2:323.
DOI
|
9 |
Fazio S, Palmieri EA, Lombardi G, Biondi B. Effects of thyroid hormone on the cardiovascular system. Recent Prog Horm Res 2004;59:31-50.
DOI
|
10 |
Napoli R, Guardasole V, Angelini V, et al. Acute effects of triiodothyronine on endothelial function in human subjects. J Clin Endocrinol Metab 2007;92:250-4.
DOI
|
11 |
Leung AM, Braverman LE. Consequences of excess iodine. Nat Rev Endocrinol 2014;10:136-42.
DOI
|
12 |
Featherstone HJ, Stewart DK. Angina in thyrotoxicosis. Thyroidrelated coronary artery spasm. Arch Intern Med 1983;143:554-5.
DOI
|
13 |
Fukuyama K, Ichiki T, Takeda K, et al. Downregulation of vascular angiotensin II type 1 receptor by thyroid hormone. Hypertension 2003;41:598-603.
DOI
|
14 |
Eliason BC. Transient hyperthyroidism in a patient taking dietary supplements containing kelp. J Am Board Fam Pract 1998;11:478-80.
DOI
|
15 |
Mussig K, Thamer C, Bares R, Lipp HP, Haring HU, Gallwitz B. Iodineinduced thyrotoxicosis after ingestion of kelp-containing tea. J Gen Intern Med 2006;21:C11-4.
|
16 |
Napoli R, Biondi B, Guardasole V, et al. Impact of hyperthyroidism and its correction on vascular reactivity in humans. Circulation 2001;104:3076-80.
DOI
|
17 |
Hermenegildo C, Medina P, Peiro M, et al. Plasma concentration of asymmetric dimethylarginine, an endogenous inhibitor of nitric oxide synthase, is elevated in hyperthyroid patients. J Clin Endocrinol Metab 2002;87:5636-40.
DOI
|
18 |
Finset A, Gerin W. How can we promote medication adherence and lifestyle changes in hypertensive patients? Patient Educ Couns 2008;72:1-2.
DOI
|
19 |
Bell RA, Kravitz RL. Physician counseling for hypertension: What do doctors really do? Patient Educ Couns 2008;72:115-21.
DOI
|
20 |
Zava TT, Zava DT. Assessment of Japanese iodine intake based on seaweed consumption in Japan: A literature-based analysis. Thyroid Res 2011;4:14.
DOI
|